Neonates with Bartter syndrome have enormous fluid and sodium requirements

Acta Paediatrica, International Journal of Paediatrics

Volumn 104, Issue 7, 2015, Pages e294-e299

  Azzi, Antonio ^a   Chehade, Hassib ^a   Deschênes, Georges ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Fluid supplementation; Indomethacin treatment; Neonatal Bartter syndrome; Sodium supplementation; Weight gain

Indexed keywords

INDOMETACIN; SODIUM; PROSTAGLANDIN SYNTHASE INHIBITOR; SODIUM INTAKE;

ARTICLE; BARTTER SYNDROME; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CORRELATION COEFFICIENT; FEMALE; FLUID THERAPY; FOLLOW UP; HUMAN; MALE; NEONATAL WEIGHT LOSS; NEWBORN; OUTCOME ASSESSMENT; POSTNATAL CARE; PRIORITY JOURNAL; TREATMENT INDICATION; WEIGHT GAIN; AGE; COHORT ANALYSIS; DIET SUPPLEMENTATION; SODIUM INTAKE; THERAPEUTIC USE;

AGE FACTORS; BARTTER SYNDROME; COHORT STUDIES; CYCLOOXYGENASE INHIBITORS; DIETARY SUPPLEMENTS; FEMALE; FLUID THERAPY; HUMANS; INDOMETHACIN; INFANT, NEWBORN; MALE; SODIUM, DIETARY; WEIGHT GAIN;

EID: 84931563136     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/apa.12981     Document Type: Article

References (14)

1. Bartter FC, Pronove P, Gill JRJ, MacCardle RC,. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis: a new syndrome. J Am Soc Nephrol 1998; 9: 516-28.
2. Schlingmann KP, Konrad M, Jeck N, Waldegger P, Reinalter SC, Holder M, et al., Salt wasting and deafness resulting from mutations in two chloride channels. N Engl J Med 2004; 350: 1314-9.
3. Konrad M, Vollmer M, Lemmink HH, van den Heuvel LP, Jeck N, Vargas-Poussou R, et al., Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol 2000; 11: 1449-59.
4. Konrad M, Leonhardt A, Hensen P,. Prenatal and postnatal management of hyperprostaglandin E syndrome after genetic diagnosis from amniocytes. Pediatrics 1999; 103: 678-83.
5. Breyer MD, Breyer RM,. Prostaglandin E receptors and the kidney. Am J Physiol Renal Physiol 2000; 279: 12-23.
6. Vaisbich MH, Fujimura MD, Koch VH,. Bartter syndrome: benefits and side effects of long-term treatment. Pediatr Nephrol 2004; 19: 858-63.
7. Deschenes G, Burguet A, Guyot C, Hubert P, Garabedian M, Dechaux M, et al., Antenatal form of Bartter's syndrome. Ann Pediatr 1993; 40: 95-101.
8. Vieux R, Hamon I, Feldmann M, André JL, Hascoët JM,. Neonatal Bartter syndrome's special features in very premature newborns. Arch Pediatr 2009; 16: 23-6.
9. Schreuder M, Wilhelm A, Bokenkamp A, Timmermans S, Henriette A, Delemarre-van de Waal H, et al., Impact of Gestational Age and Birth Weight on Amikacin Clearance on Day 1 of Life. Clin J Am Soc Nephrol 2009; 4: 1774-8.
10. Reinalter S, Jeck N, Brochhausen C, Watzer B, Nüsing R, Seyberth H, et al., Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome. Kidney Int 2002; 62: 253-60.
11. Bockenhauer D, Cruwys M, Kleta R, Halperin LF, Wildgoose P, Souma T, et al., Antenatal Bartter's syndrome: why is this not a lethal condition? QJM 2008; 101: 927-42.
12. Finer G, Shalev H, Birk OS, Galron D, Jeck N, Sinai-Treiman L, et al., Transient neonatal hyperkalemia in the antenatal (ROMK defective) Bartter syndrome. J Pediatr 2003; 142: 318-23.
13. Peters M, Jeck N, Reinalter S, Leonhardt A, Tönshoff B, Klaus GG, et al., Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med 2002; 112: 183-90.
14. Simon DB, Bindra RS, Mansfield TA, Nelson-Williams C, Mendonca E, Stone R, et al., Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet 1997; 17: 171-8.